Related Experiment Video
Updated: Mar 15, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Neuroimaging evidence of microstructural alteration in Parkinson's disease with subjective cognitive decline
Kaidong Chen1, Ruixuan Zhang1, Yi Ji1
1Department of Radiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
Abstract:
Subjective cognitive decline (SCD) may represent a special cognitive stage distinct from mild cognitive impairment (MCI) in Parkinson's disease (PD), but its microstructural correlates are underexplored. We aimed to investigate microstructural alterations in PD-SCD compared to PD with normal cognition (PD-NC) and PD-MCI, and to explore their association with cognitive status. 68 PD patients (PD-NC: n = 23; PD-SCD: n = 20; PD-MCI: n = 25) and 27 healthy controls (HC) underwent multimodal MRI. Analyses included tract-based spatial statistics (TBSS), calculation of the peak width of skeletonized mean diffusivity (PSMD), and hippocampal subfield segmentation. PSMD showed significant differences across subgroups and negatively correlated with MoCA scores, suggesting its utility as a metric that differentiated cognitive stage. TBSS revealed reduced fractional anisotropy (FA) in multiple tracts in PD-MCI, while PD-SCD exhibited reduced FA only in FMajor relative to HC. Hippocampal subfield segmentation revealed atrophy in subregions such as CA1 and HATA in PD-SCD and PD-MCI compared to PD-NC. This study provides evidence that microstructural alterations are already detectable at the PD-SCD stage. PSMD emerges as a sensitive cross-sectional biomarker of PD cognitive staging. These findings highlight the potential role of white‑matter changes in PD‑related cognitive complaints.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
Related Concept Videos
Neural Regulation
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview